Gene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in...
Read More